T.Rx Capital Fund I, LP — Form D/A
T.Rx Capital Fund I, LP of Boston, MA, a pooled investment fund, filed a Form D amendment with the SEC on 2025-09-17. The offering totals $175.0M, of which $77.2M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2025-09-17
- Form: D/A
- Accession: 0001123292-25-000443
- Industry: Pooled Investment Fund
- Exemptions: 3C.7, 06b, 3C
- Total offering: $175.0M
- Amount sold: $77.2M
- Remaining: $97.8M
- Investors: 48
- Date of first sale: 2024-02-05
- Security types: equity, fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-504691
Issuer
- Name: T.Rx Capital Fund I, LP
- CIK: 0001968662
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2023
- Address: 135 Seaport Blvd, Boston, MA, 02210
- Phone: 617-543-8698
Officers, directors & promoters (3)
| Name | Role | Location |
|---|
| Kwesi Frimpong-Boateng | Executive Officer | New Jersey, NJ |
| Michael Langer | Executive Officer | Boston, MA |
| N/A T. Rx Capital Fund I GP, LLC | Executive Officer | Boston, MA |
Other filings by this issuer (2)
More